Neang S. Ly, Ph.D.
Affiliations: | 2014 | Pharmaceutical Sciences | State University of New York, Buffalo, Buffalo, NY, United States |
Google:
"Neang Ly"Parents
Sign in to add mentor| Donald E. Mager | grad student | 2014 | SUNY Buffalo | |
| (Optimizing polymyxin antibiotics using combination therapy and mechanism-based models.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bulman ZP, Ly NS, Lenhard JR, et al. (2017) Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa: Implications for Quorum Sensing Inhibition with Azithromycin. Antimicrobial Agents and Chemotherapy |
| Sharma R, Patel S, Abboud C, et al. (2016) Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes. International Journal of Antimicrobial Agents |
| Wittau M, Paschke S, Kurlbaum M, et al. (2016) Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery. Antimicrobial Agents and Chemotherapy |
| Rao GG, Ly NS, Bulitta JB, et al. (2016) Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies. The Journal of Antimicrobial Chemotherapy |
| Rao GG, Ly NS, Diep J, et al. (2016) Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii. International Journal of Antimicrobial Agents |
| Ly NS, Bulman ZP, Bulitta JB, et al. (2016) Optimization of Polymyxin B in Combination with Doripenem to Combat Mutator Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy |
| Bulman ZP, Sutton MD, Ly NS, et al. (2015) Emergence of Polymyxin B Resistance Influences Pathogenicity in Pseudomonas aeruginosa Mutators. Antimicrobial Agents and Chemotherapy. 59: 4343-6 |
| Ly NS, Bulitta JB, Rao GG, et al. (2015) Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance. The Journal of Antimicrobial Chemotherapy. 70: 1434-42 |
| Bulitta JB, Ly NS, Landersdorfer CB, et al. (2015) Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling. Antimicrobial Agents and Chemotherapy. 59: 2315-27 |
| Rao GG, Ly NS, Haas CE, et al. (2014) New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease. Antimicrobial Agents and Chemotherapy. 58: 1381-8 |